Oncoinvent ASA

Research Oncoinvent ASA (ONCIN) on Bullrun: market cap NOK 214.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerONCIN
• ExchangeOL
• CountryNorway
• SectorHealthcare
• IndustryBiotechnology
• CurrencyNOK
• Market capNOK 214.96M
• Financial periodFY2025
• RevenueNOK 28.07M
• Revenue growth246.5%
• Net income-NOK 155.07M
• Free cash flow-NOK 129.99M
• Gross margin100.0%

Valuation Snapshot

latest market cap is NOK 214.96M.

About Oncoinvent ASA

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. Oncoinvent ASA is based in Oslo, Norway.

Frequently asked questions

What is Oncoinvent ASA's market cap?

Oncoinvent ASA's market capitalization is NOK 214.96M.

What does Oncoinvent ASA do?

Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized...